Effects of berberine on β-secretase activity in a rabbit model of Alzheimer's disease

Archives of Medical Science

Volumn 9, Issue 1, 2013, Pages 146-150

  Panahi, Negar ^a   Mahmoudian, Massoud ^b   Mortazavi, Pejman ^a   Hashjin, Goudarz Sadeghi ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

Author keywords

secretase; Aluminium maltolate; Alzheimer's disease; Berberine; Hippocampus

Indexed keywords

ALUMINUM MALTOL; BERBERINE CHLORIDE; BERBINE DERIVATIVE; BETA SECRETASE; BETA SECRETASE 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; NONHUMAN; RABBIT;

EID: 84874846733     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2013.33354     Document Type: Article

References (14)

1. Lesli R. Imaging Alzheimer's disease in vivo: not so implaque-able anymore. Trends Neurosci 2002; 25: 232-3.
2. Parihar MS, Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J Clin Neurosci 2004; 11: 456-67.
3. Torreilles F, Touchan J. Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer's disease. Prog Neurobiol 2002; 66: 191-203.
4. Vassar R, Citron M. Ab-generating enzymes recent advances in beta and gamma-secretase research. Neuron 2000; 27: 419-22.
5. Vassar R. Beta-secretase (BACE) as a drug target for Alzheimer's disease. Adv Drug Delivery Rev 2002; 54: 1589-602.
6. Caiyun Q, Zhu F. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1 beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci 2006; 7: 78.
7. Bertholf R, Hermann M, Savory J, et al. A long term intravenous model of aluminum maltol toxicity in rabbits. Toxicol Appl Pharmacol 1989; 98: 58-74.
8. Bharathi SN, Sathyanarayana T, Dhanunjaya NM, Ra - vid R, Rao K. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model. Brain Res Rev 2006; 52: 275-92.
9. Savory J, Hermann M, Ghribi O. Mechanism of aluminiuminduced neurodegeneration in animals: implication for Alzheimer's disease. J Alzheimer's Dis 2006; 10: 135-44.
10. Shuto D, Kasai S, Kimura T, et al. KMI-800, a novel betasecretase Inhibitor containing a hydroxymethylcarbonyl isostere as a transition-state mimic: design and synthesis of substrate-based octapeptides. Bioorganic Medicinal Lett 2003; 13: 4273-6.
11. Geng DS, Liu FA, Liu XB, Yang Y. Effects of berberine sulphate on immune system. Chin Pharmacol Bul 1996; 12: 536-9.
12. Kumazawa Y, Itagaki A, Fukumoto M, Fujisawa H, Nishimura C, Nomoto K. Activation of peritoneal macrophages by berberine type alkaloids in terms of induction of cytostatic activity. Int J Immunopharmacol 1984; 6: 587-92.
13. Hung C, Zhang Y, Gong Z, et al. Berberine inhibits 3T3-IL adipocyte differentiation through the PPAR gamma pathway. Biochem Biophys Res Commun 2006; 348: 571-8.
14. Zhou L, Chen M, Wang X, Song H, Yang Y. Effect of berberine on the differentiation of adipocyte. Natl Med J China 2003; 83: 338-40.